199 related articles for article (PubMed ID: 17706180)
1. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
2. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
3. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
Crotts G; Park TG
J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
5. [New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres].
Blanco-Prieto MJ; Fattal E; Puisieux F; Couvreur P
Ann Pharm Fr; 1998; 56(6):256-63. PubMed ID: 9872012
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
Song W; Kong HL; Traktman P; Crystal RG
Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
[TBL] [Abstract][Full Text] [Related]
8. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K.
Rawle FC; Tollefson AE; Wold WS; Gooding LR
J Immunol; 1989 Sep; 143(6):2031-7. PubMed ID: 2789254
[TBL] [Abstract][Full Text] [Related]
9. Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo.
Beer SJ; Matthews CB; Stein CS; Ross BD; Hilfinger JM; Davidson BL
Gene Ther; 1998 Jun; 5(6):740-6. PubMed ID: 9747453
[TBL] [Abstract][Full Text] [Related]
10. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
Challacombe SJ; Rahman D; Jeffery H; Davis SS; O'Hagan DT
Immunology; 1992 May; 76(1):164-8. PubMed ID: 1628895
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres.
Walker KB; Xing DK; Sesardic D; Corbel MJ
Dev Biol Stand; 1998; 92():259-67. PubMed ID: 9554281
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
[TBL] [Abstract][Full Text] [Related]
13. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres.
Martinez B; Lairion F; Pena MB; Di Rocco P; Nacucchio MC
J Microencapsul; 1997; 14(2):155-61. PubMed ID: 9132467
[TBL] [Abstract][Full Text] [Related]
14. Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses.
Newman KD; Sosnowski DL; Kwon GS; Samuel J
J Pharm Sci; 1998 Nov; 87(11):1421-7. PubMed ID: 9811500
[TBL] [Abstract][Full Text] [Related]
15. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
16. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
Bright RK; Beames B; Shearer MH; Kennedy RC
Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL
J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430
[TBL] [Abstract][Full Text] [Related]
18. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery.
Wang D; Robinson DR; Kwon GS; Samuel J
J Control Release; 1999 Jan; 57(1):9-18. PubMed ID: 9863034
[TBL] [Abstract][Full Text] [Related]
19. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
Uchida T; Goto S; Foster TP
J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation in vitro and vivo of copoly (lactic/glycolic) acid microspheres containing norethisterone.
Zhou Z; Zhou M; Wang S; Lin F; Shan W
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(1):71-84. PubMed ID: 8461438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
